Datasheet | May 17, 2021

Antibody Development With BIOVIA Discovery Studio

Source: Dassault Systèmes


Antibodies have proven to be an effective treatment in a number of key diseases, including cancer, chronic inflammatory diseases, cardiovascular diseases, immune disorders, as well as infectious diseases. Because of this potential, antibodies now represent one of the fastest growing classes of human therapeutic drugs. With BIOVIA Discovery Studio, not only do you have the tools necessary to model antibody structures in an easy to use environment, but it also delivers the essential science to optimize their efficacy and pharmaceutical developability as therapeutic agents.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online